NXPE1_pcDNA3.4-TOPO Citations (4)
Originally described in: NXPE1 Protein Producing PlasmidUnpublished
Articles Citing NXPE1_pcDNA3.4-TOPO
| Articles |
|---|
| The Glycosyltransferase XYLT1 Activates NF-kappaB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma. Han J, Du J, Li X, Zhou Q, Zeng J, Lin JT, Zhou W, Cai J, Ye Y, Yang B, Wang J, Zhou X, Lian R, Yang Y, Zhu X, Guan H, Liu L, Cai J, Wu J, Li Y, Li M, Tian H. Cancer Res. 2025 May 2;85(9):1628-1643. doi: 10.1158/0008-5472.CAN-24-1893. PubMed |
| NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon. Lee BS, Cook A, Sur S, Dobbyn L, Popoli M, Khalili S, Zhou S, Bettegowda C, Papadopoulos N, Gabrielson K, Buckhaults P, Vogelstein B, Kinzler KW, Wyhs N. Nat Commun. 2025 May 27;16(1):4912. doi: 10.1038/s41467-025-59671-9. PubMed |
| Development of recombinant Mesozumab-CPTin that dual-targets mesothelin and CP2c for anticancer therapy. Kim B, Byun KT, Cho J, Lee I, Park D, Kang TB, Won HS, Cheon SY, Kim CG. Biomed Pharmacother. 2025 Dec;193:118799. doi: 10.1016/j.biopha.2025.118799. Epub 2025 Nov 20. PubMed |
| Development of a HER1/CP2c dual-targeting biopharmaceutical for HER1-overexpressing head and neck cancer. Byun KT, Cho J, Kim B, Lee I, Kim EB, Park D, Han SW, Won HS, Cheon SY, Kim CG. Biomater Adv. 2026 Jun;183:214782. doi: 10.1016/j.bioadv.2026.214782. Epub 2026 Feb 18. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.